Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Leopoldo Fernandez-Alonso"'
Autor:
Sebastian Fernandez-Alonso, MD, Marina Lopez-San Martin, MD, Leopoldo Fernandez-Alonso, MD, PhD, Esther Martinez-Aguilar, MD, PhD, Estefana Santamarta-Fariña, MD, Roberto Centeno-Vallepuga, MD
Publikováno v:
Journal of Vascular Surgery Cases and Innovative Techniques, Vol 7, Iss 1, Pp 100-103 (2021)
Our patient had undergone a previous three-fenestration Anaconda (Terumo Medical Corp, Tokyo, Japan) fenestrated endovascular aneurysm repair (EVAR) to treat a juxtarenal aortic aneurysm. At 10 years postoperatively, distal migration of the prosthesi
Externí odkaz:
https://doaj.org/article/390d97ef0ca44bbbba6d45e7e28bf804
Autor:
Sebastian Fernandez-Alonso, Esther Martinez-Aguilar, Susana Ravassa, Josune Orbe, Jose A. Paramo, Leopoldo Fernandez-Alonso, Carmen Roncal
Publikováno v:
Life, Vol 12, Iss 6, p 823 (2022)
Predicting the progression of small aneurysms is a main challenge in abdominal aortic aneurysm (AAA) management. The combination of circulating biomarkers and image techniques might provide an alternative for risk stratification. We evaluated the ass
Externí odkaz:
https://doaj.org/article/4806e38f50454467b3d17531b1e3dac7
Autor:
Goren Saenz-Pipaon, Susana Ravassa, Katrine L. Larsen, Esther Martinez-Aguilar, Josune Orbe, Jose A. Rodriguez, Leopoldo Fernandez-Alonso, Arantxa Gonzalez, Jose L. Martín-Ventura, Jose A. Paramo, Jes S. Lindholt, Carmen Roncal
Publikováno v:
Saenz-Pipaon, G, Ravassa, S, Larsen, K L, Martinez-Aguilar, E, Orbe, J, Rodriguez, J A, Fernandez-Alonso, L, Gonzalez, A, Martín-Ventura, J L, Paramo, J A, Lindholt, J S & Roncal, C 2022, ' Lipocalin-2 and Calprotectin Potential Prognosis Biomarkers in Peripheral Arterial Disease ', European Journal of Vascular and Endovascular Surgery, vol. 63, no. 4, pp. 648-656 . https://doi.org/10.1016/j.ejvs.2022.01.012
Objective: Peripheral arterial disease (PAD) is the most prevalent cardiovascular (CV) condition globally. Despite the high CV risk of PAD patients, no reliable predictors of adverse clinical evolution are yet available. In this regard, previous tran
Autor:
David Moreno-Ajona, Pablo Irimia, José Antonio Rodríguez, María José García-Velloso, Jesús López-Fidalgo, Leopoldo Fernández-Alonso, Lukasz Grochowitz, Roberto Muñoz, Pablo Domínguez, Jaime Gállego-Culleré, Eduardo Martínez-Vila
Publikováno v:
BMC Cardiovascular Disorders, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background Major adverse cardiovascular events are the main cause of morbidity and mortality over the long term in patients undergoing carotid endarterectomy. There are few reports assessing the prognostic value of markers of inflammation in
Externí odkaz:
https://doaj.org/article/70059fb83aeb4256910d71de960064bd